Safety and Efficacy of Low-Dose Bexarotene and PUVA in the Treatment of Patients with Mycosis Fungoides

Bexarotene Is Effective and Safe for Treatment of Refractory Advanced-Stage Cutaneous T-Cell Lymphoma: Multinational Phase II-III Trial Results

Madeleine Duvic, Kenneth B. Hymes, Peter Heald et al. · Journal of Clinical Oncology · 2001 · 704 citations

Medicine, Oncology, Pharmacology +14

Report of the Committee on Staging and Classification of Cutaneous T-Cell Lymphomas.

Bunn Pa, Lamberg Si · PubMed · 1979 · 544 citations

Medicine, Dermatology, Oncology +11

Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma.

Madeleine Duvic, Ángel G. Martín, Y. Kim et al. · PubMed · 2001 · 438 citations

Medicine, Pharmacology, Pharmacotherapy +14

Treatment of mycosis fungoides with photochemotherapy (PUVA): Long-term follow-up

James J. Herrmann, Henry H. Roenigk, Arti Hurria et al. · Journal of the American Academy of Dermatology · 1995 · 232 citations

Life Sciences, Dermatology, Mycology +1

Photochemotherapy Alone or Combined with Interferon Alpha-2a in the Treatment of Cutaneous T-Cell Lymphoma

Henry H. Roenigk, Timothy M. Kuzel, Alexandra P. Skoutelis et al. · Journal of Investigative Dermatology · 1990 · 143 citations · Full text

Medicine, Dermatology, Oncology +5